Spire Healthcare Group (LON:SPI – Get Free Report) announced its earnings results on Wednesday. The company reported GBX (0.50) earnings per share for the quarter, Digital Look Earnings reports. Spire Healthcare Group had a net margin of 1.04% and a return on equity of 2.22%.
Spire Healthcare Group Stock Up 0.2%
Shares of Spire Healthcare Group stock traded up GBX 0.50 on Wednesday, reaching GBX 246. The stock had a trading volume of 2,104,264 shares, compared to its average volume of 5,405,250. The company has a quick ratio of 0.73, a current ratio of 0.63 and a debt-to-equity ratio of 177.14. The stock has a market capitalization of £985.47 million, a P/E ratio of 61.50, a P/E/G ratio of 1.06 and a beta of 0.93. The company has a 50 day moving average price of GBX 237.57 and a 200 day moving average price of GBX 207.17. Spire Healthcare Group has a 1 year low of GBX 140.80 and a 1 year high of GBX 251.50.
Wall Street Analyst Weigh In
Separately, Royal Bank Of Canada downgraded shares of Spire Healthcare Group to a “sector perform” rating and decreased their price objective for the stock from GBX 300 to GBX 250 in a research note on Monday, September 7th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of GBX 247.50.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
Featured Stories
- Five stocks we like better than Spire Healthcare Group
- Arhaus Has New Momentum—Could Other Furniture Stocks Be Next?
- Can Boxabl Turn Modular Homes Into AI Data Center Infrastructure?
- Up All Night: How Nasdaq’s 23-Hour Trading Could Wake Up Wall Street
- 4 Stocks That Could Split Next—and Why Investors Are Watching
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.
